Luxury home builder Glenville has won an appeal of a ruling that shielded certain documents from production by legal professional privilege in a lawsuit against global packaging giant Amcor over liability for asbestos remediation at a former Amcor paper mill site in a Melbourne suburb.
The High Court has rejected a bid by biopharmaceutical company Samsung Bioepis Australia to challenge a ruling granting Pfizer preliminary discovery for a potential patent infringement case over autoimmune drug Enbrel.
Pharmaceutical giant Wyeth’s has launched an “ambush” at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement of a second patent for its blockbuster Effexor-XR, a judge heard Monday.
Law firm Squire Patton Boggs is appealing a ruling that permanently stayed its case against technology startup GetSwift in favour of a competing class action.
In the wake of a major ruling approving a wage class action against fundraiser Appco, more “sham” contracting suits were launched Monday, this time against two international direct marketing companies.
A judge has denied a bid for summary judgment by Garmin Australia in a lawsuit brought by the GPS giant seeking $1.1 million allegedly owed under an agreement to supply its products for sale in Australia.
Commonwealth Bank of Australia will pay $700 million to settle claims of lax anti-money laundering oversight.
The Australian Building and Construction Commissioner has lost its challenge to a Federal Court decision dismissing allegations that the Construction, Forestry, Mining and Energy Union engaged in unlawful industrial action in Canberra in 2014.
The Fair Work Commission has announced adjustments to both the national minimum wage and modern award minimum wages, in a move it says strikes a balance between improving conditions for low income earners and promoting job supply.
A decade-long courtroom battle over a patent for Effexor-XR that delayed the release of cheap versions of the anti-depressant is at the centre of a trial starting Monday in Sydney pitting four generic drug makers against pharmaceutical giant Wyeth.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
